Activity value 80International Buyer&Supplier,Last transaction date:
2026-02-24Address: terminal beograd novosadski put bb serbia
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for medi co plus d.o.o. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 148 transactions, with a transaction quantity of 2302120.88 and a transaction weight of 123749.88.
YearTransactionsQuantityWeight
20255518210801.771353880.17
20261482302120.88123749.88
Bill of lading data
<
1/15
>
Trade date
2026/02/24
B/L No.
8103282
Suppliers
axelia
Buyers
medi co plus d.o.o.
POLs
jawaharlal nehru (nhava sheva)
PODs
matadi
Supply area
India
Purchas area
The Democratic Republic Of The Congo
Weight
——
Amount
894836.69
Hs code
30049029
Product tags
ma cr,betamethasone,betamethasone dipropionate,clotrimazole
Product description
ZEMA CREAM BETAMETHASONE DIPROPIONATE U S P EQ TO BETAMETHASONE USP 0 05 % W W + CLOTRIMAZOLE USP 1 % W W + GENTAM
Expand
Trade date
2026/02/24
B/L No.
5561463
Suppliers
axelia
Buyers
medi co plus d.o.o.
POLs
jawaharlal nehru (nhava sheva)
PODs
matadi
Supply area
India
Purchas area
The Democratic Republic Of The Congo
medi co plus d.o.o. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as injection,mg tablet,tablet.
According to the 52wmb.com global trade database, as of 2026-02-24, the company has completed 4184 international trades,
with its main trading regions covering india,turkey,china etc.
The core products include HS30049099,HS30046000,HS30049069 etc,
often transported via matadi,port dar es salaam, port tztm etc,
and its main trading partners are axelia,synmex pharma,savorite pharmaceuticals.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on medi co plus d.o.o. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.